108 related articles for article (PubMed ID: 18904)
1. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
Julou L; Scatton B; Glowinski J
Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
[No Abstract] [Full Text] [Related]
2. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
Glowinski J
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
[No Abstract] [Full Text] [Related]
3. Regional and ultrastructural localization of tyrosine hydroxylass by immunocytochemistry in dopaminergic neurons of the mesolimbic and nigroneostriatal systems.
Pickel VM; Joh TH; Reis DJ
Adv Biochem Psychopharmacol; 1977; 16():321-9. PubMed ID: 18885
[No Abstract] [Full Text] [Related]
4. Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.
Scatton B; Boireau A; Garret C; Glowinski J; Julou L
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):169-75. PubMed ID: 13318
[No Abstract] [Full Text] [Related]
5. Acute and chronic haloperidol treatment: effects on nigrostriatal dopaminergic system activity.
Bunney BS; Skirboll LR; Grace AA
Adv Biochem Psychopharmacol; 1980; 24():267-73. PubMed ID: 7405666
[No Abstract] [Full Text] [Related]
6. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
Bartholini G
Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
[No Abstract] [Full Text] [Related]
7. [Biochemical mechanism of action of neuroleptics (author's transl)].
Scatton B
Encephale; 1981; 7(3):201-14. PubMed ID: 6116590
[TBL] [Abstract][Full Text] [Related]
8. Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.
Kelland MD; Chiodo LA; Freeman AS
Synapse; 1990; 6(2):207-9. PubMed ID: 1978421
[No Abstract] [Full Text] [Related]
9. Dynamic changes in the activities and amounts of neurotransmitter-synthesizing enzymes in mesolimbic and other central catecholamine neurons in response to axonal injury and during collateral sprouting.
Reis DJ; Gilad GM; Pickel VM; Ross RA; Joh TH
Adv Biochem Psychopharmacol; 1977; 16():331-41. PubMed ID: 18886
[No Abstract] [Full Text] [Related]
10. N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.
Jacobowitz DM; Burns RS; Chiueh CC; Kopin IJ
Psychopharmacol Bull; 1984; 20(3):416-22. PubMed ID: 6332329
[No Abstract] [Full Text] [Related]
11. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
Koob GF; Del Fiacco M; Iversen SD
Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
[No Abstract] [Full Text] [Related]
12. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.
Clarke PB; Pert A
Brain Res; 1985 Dec; 348(2):355-8. PubMed ID: 4075093
[TBL] [Abstract][Full Text] [Related]
13. Localization of cholecystokinin receptors in relation to the nigrostriatal and mesolimbic dopaminergic pathways.
Gaudreau P; Quirion R; St-Pierre S; Chiueh CC; Pert A
Neuropeptides; 1987; 9(4):283-93. PubMed ID: 3614556
[TBL] [Abstract][Full Text] [Related]
14. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
Granado N; O'Shea E; Bove J; Vila M; Colado MI; Moratalla R
J Neurochem; 2008 Nov; 107(4):1102-12. PubMed ID: 18823368
[TBL] [Abstract][Full Text] [Related]
15. [3H]DPDPE binding to delta opioid receptors in the rat mesocorticolimbic and nigrostriatal pathways is transiently increased by acute ethanol administration.
Méndez M; Morales-Mulia M; Leriche M
Brain Res; 2004 Dec; 1028(2):180-90. PubMed ID: 15527743
[TBL] [Abstract][Full Text] [Related]
16. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
Date I; Asari S; Nishimoto A; Felten DL
No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
[TBL] [Abstract][Full Text] [Related]
17. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
18. [Chronology of the extrapyramidal effects of neuroleptics, and the nigrostriatal dopaminergic system].
Petit M; Lepine JP; Lesieur P
Encephale; 1979; 5(4):297-316. PubMed ID: 42527
[TBL] [Abstract][Full Text] [Related]
19. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions.
Menegoz M; Lau LF; Hervé D; Huganir RL; Girault JA
Neuroreport; 1995 Dec; 7(1):125-8. PubMed ID: 8742433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
